Treatment to reduce edema
US5488033A · kind A · utility
4Cited by
13References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 19, 1994 |
| Grant date | Jan 30, 1996 |
| Priority date | — |
| Expiry date | Apr 19, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N1/122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administration of a corticotropin-releasing factor (or a salt or analog thereof) decreases the leakage of blood components into tissues produced by various adverse medical conditions. Thus, treatments with corticotropin-releasing factor are useful in systemic inflammatory conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.